Related Experiment Video
Updated: Aug 21, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias
M Perez-Andres1, J Almeida, M Martin-Ayuso
1Service of Citometry and Department of Medicine, University of Salamanca, Salamanca, Spain.
Abstract:
The term "monoclonal gammopathy" (MG) includes a group of clonal plasma cell disorders, which show heterogeneous clinical behavior. While multiple myeloma (MM) and plasma cell leukemia (PCL) are incurable malignant diseases, most patients with MG of undetermined significance (MGUS) show an indolent/benign clinical course. Evidence has accumulated which supports the role of the bone marrow microenvironment in MG. Accordingly, the survival, drug-resistance and proliferation of MM cells have been shown to be largely dependent on a supportive microenvironment. Among the different environment-associated parameters, those related to the status/activity of the immune system are particularly relevant. This review focuses on the different ways clonal plasma cells (PC) interact with the immune system in different models of MG, to characterize crucial events in the development and progression of MG. These advances may support the design of novel therapeutic approaches in patients with MG.
Insights
Monoclonal gammopathy (MG) encompasses plasma cell disorders with varied clinical outcomes. This review explores how clonal plasma cells interact with the immune system, offering insights for new therapeutic strategies in MG.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Monoclonal gammopathy (MG) comprises diverse clonal plasma cell disorders.
- Multiple myeloma (MM) and plasma cell leukemia (PCL) are malignant, while MG of undetermined significance (MGUS) is typically benign.
- The bone marrow microenvironment significantly influences MG pathogenesis, particularly MM cell survival and drug resistance.
Purpose of the Study:
- To review the interactions between clonal plasma cells (PC) and the immune system in various MG models.
- To identify critical events in the development and progression of MG.
- To inform the development of novel therapeutic strategies for MG patients.
Main Methods:
- Literature review focusing on immune system interactions in monoclonal gammopathy.
- Analysis of mechanisms underlying clonal plasma cell behavior within the bone marrow microenvironment.
- Synthesis of current evidence on immune system modulation in MG.
Main Results:
- Clonal plasma cells engage in complex interactions with immune system components.
- The immune microenvironment plays a crucial role in the progression of MG, from MGUS to MM.
- Understanding these interactions is key to differentiating indolent from malignant forms of MG.
Conclusions:
- Immune system interactions are central to the pathogenesis and clinical heterogeneity of monoclonal gammopathies.
- Targeting these interactions holds promise for developing innovative therapies.
- Further research into the MG-immune system crosstalk can lead to improved patient outcomes.
More Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
Cell-mediated Immune Responses
Humoral Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

